CSDE1
Basic information
Region (hg38): 1:114716913-114758676
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSDE1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 76 | 82 | ||||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 7 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 5 | |||||
Total | 4 | 4 | 86 | 6 | 5 |
Highest pathogenic variant AF is 0.0000131
Variants in CSDE1
This is a list of pathogenic ClinVar variants found in the CSDE1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-114716959-T-C | Likely benign (Jun 23, 2018) | |||
1-114716978-G-T | Benign (Jun 13, 2019) | |||
1-114718159-G-C | CSDE1-related disorder | Likely benign (Jul 24, 2019) | ||
1-114718188-T-G | Inborn genetic diseases | Uncertain significance (May 17, 2024) | ||
1-114718191-CG-C | Uncertain significance (Aug 30, 2022) | |||
1-114718204-C-G | Uncertain significance (Apr 21, 2021) | |||
1-114718221-G-A | CSDE1-related disorder | Likely benign (Mar 16, 2022) | ||
1-114718221-G-T | Inborn genetic diseases • CSDE1-related disorder | Benign (Dec 09, 2021) | ||
1-114718222-G-T | Inborn genetic diseases | Uncertain significance (Sep 19, 2022) | ||
1-114718626-G-C | CSDE1-associated neurodevelopmental disorder | Uncertain significance (Jun 11, 2021) | ||
1-114718641-C-T | CSDE1-related disorder | Uncertain significance (Aug 02, 2023) | ||
1-114718642-G-A | Uncertain significance (May 25, 2022) | |||
1-114718744-C-G | Inborn genetic diseases | Uncertain significance (Jun 17, 2024) | ||
1-114719589-A-G | Inborn genetic diseases | Uncertain significance (Jan 07, 2025) | ||
1-114719648-T-C | Uncertain significance (Mar 03, 2023) | |||
1-114719654-C-G | Inborn genetic diseases | Uncertain significance (Nov 08, 2024) | ||
1-114719661-G-A | CSDE1-associated disorder | Likely pathogenic (Jul 21, 2020) | ||
1-114719693-T-C | Uncertain significance (Jun 05, 2024) | |||
1-114719698-A-G | CSDE1-related disorder | Benign (Dec 01, 2022) | ||
1-114719725-ATAGT-A | Pathogenic (Mar 14, 2025) | |||
1-114719746-A-G | Benign (May 18, 2018) | |||
1-114720531-G-A | CSDE1-related disorder | Likely benign (Aug 08, 2019) | ||
1-114720570-C-T | Uncertain significance (Sep 19, 2024) | |||
1-114720582-A-T | Uncertain significance (Aug 23, 2024) | |||
1-114720589-A-G | Uncertain significance (Aug 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CSDE1 | protein_coding | protein_coding | ENST00000438362 | 19 | 41764 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000368 | 125742 | 0 | 5 | 125747 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.45 | 259 | 469 | 0.552 | 0.0000252 | 5578 |
Missense in Polyphen | 53 | 155.68 | 0.34043 | 1836 | ||
Synonymous | 0.403 | 155 | 162 | 0.960 | 0.00000829 | 1619 |
Loss of Function | 5.85 | 2 | 43.8 | 0.0456 | 0.00000253 | 510 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein. Required for internal initiation of translation of human rhinovirus RNA. May be involved in translationally coupled mRNA turnover. Implicated with other RNA- binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding- region determinant of instability (mCRD) domain. {ECO:0000269|PubMed:11051545, ECO:0000269|PubMed:15314026}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Validated targets of C-MYC transcriptional repression
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.0149
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.32
Haploinsufficiency Scores
- pHI
- 0.712
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Csde1
- Phenotype
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;male gonad development;nuclear-transcribed mRNA catabolic process, no-go decay
- Cellular component
- Golgi apparatus;cytosol;plasma membrane;CRD-mediated mRNA stability complex
- Molecular function
- DNA binding;RNA binding;protein binding